1xls: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1xls.png|left|200px]] | [[Image:1xls.png|left|200px]] | ||
{{STRUCTURE_1xls| PDB=1xls | SCENE= }} | {{STRUCTURE_1xls| PDB=1xls | SCENE= }} | ||
===Crystal structure of the mouse CAR/RXR LBD heterodimer bound to TCPOBOP and 9cRA and a TIF2 peptide containg the third LXXLL motifs=== | ===Crystal structure of the mouse CAR/RXR LBD heterodimer bound to TCPOBOP and 9cRA and a TIF2 peptide containg the third LXXLL motifs=== | ||
{{ABSTRACT_PUBMED_15610733}} | {{ABSTRACT_PUBMED_15610733}} | ||
==About this Structure== | ==About this Structure== | ||
[[1xls]] is a 16 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1XLS OCA]. | |||
==See Also== | |||
*[[Retinoid X receptor|Retinoid X receptor]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:015610733</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Mus musculus]] | [[Category: Mus musculus]] | ||
| Line 37: | Line 28: | ||
[[Category: Lbd]] | [[Category: Lbd]] | ||
[[Category: Nuclear receptor]] | [[Category: Nuclear receptor]] | ||
[[Category: Transcription]] | |||
[[Category: Xenobiotic]] | [[Category: Xenobiotic]] | ||
Revision as of 08:04, 20 October 2012
Crystal structure of the mouse CAR/RXR LBD heterodimer bound to TCPOBOP and 9cRA and a TIF2 peptide containg the third LXXLL motifs
Template:ABSTRACT PUBMED 15610733
About this Structure
1xls is a 16 chain structure with sequence from Homo sapiens and Mus musculus. Full crystallographic information is available from OCA.
See Also
Reference
- Suino K, Peng L, Reynolds R, Li Y, Cha JY, Repa JJ, Kliewer SA, Xu HE. The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization. Mol Cell. 2004 Dec 22;16(6):893-905. PMID:15610733 doi:10.1016/j.molcel.2004.11.036